OneMedNet (NASDAQ:ONMD) CEO Aaron Green Sells 5,000 Shares of Stock

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green sold 5,000 shares of OneMedNet stock in a transaction dated Tuesday, September 22nd. The shares were sold at an average price of $7.39, for a total value of $36,950.00. Following the transaction, the chief executive officer directly owned 249,638 shares in the company, valued at approximately $1,844,824.82. The trade was a 1.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Aaron Green also recently made the following trade(s):

• On Thursday, September 24th, Aaron Green sold 1,667 shares of OneMedNet stock. The shares were sold at an average price of $6.48, for a total value of $10,802.16.

OneMedNet Stock Down 10.8%

NASDAQ ONMD traded down $0.52 during trading hours on Friday, hitting $4.30. 24,653 shares of the company were exchanged, compared to its average volume of 69,105. OneMedNet Corporation has a 52 week low of $4.30 and a 52 week high of $42.20. The stock has a market cap of $25.50 million, a PE ratio of -2.69 and a beta of 1.14. The stock has a 50-day moving average price of $6.24 and a 200 day moving average price of $7.32.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company has an average rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.